DiaMedica Therapeutics Inc (NASDAQ:DMAC)

Delayed Data
As of Aug 13
 +0.07 / +1.32%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for DiaMedica Therapeutics Inc have a median target of 14.00, with a high estimate of 15.00 and a low estimate of 14.00. The median estimate represents a +160.71% increase from the last price of 5.37.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in DiaMedica Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.80%
Growthannually 25.47%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.